In parallel, we investigated the ability of SA16 and IB35 to inhibit Aurora kinase A phosphorylation at the Thr288 site in pancreatic cancer cell lines synchronized with nocodazole (200 ng/mL). Here, AURKA is linked to pancreatic neoplasm.